Connect with us
  • Elysium


NR Headlines: Friday 14th June

Welcome to your daily roundup of everything happening in the world of neurorehab.



Welcome to your daily roundup of everything happening in the world of neurorehab.



Blood transfusions could mean better outcomes in TBI

Increased use of blood transfusions after major traumatic brain injury could help people hospitalized in intensive care units regain greater functional independence and a better quality of life.  

Six months after a major traumatic brain injury (TBI), patients who benefited from this approach regained more functional independence and had a better quality of life than those subjected to a more restrictive approach, even though the combined incidence of death and major disability was not significantly different between the two treatment groups. This is the conclusion of a new study published in the New England Journal of Medicine. 

Davos Alzheimer’s Collaborative launches global effort to streamline diagnosis of Alzheimer’s

The global organisation seeking to cure Alzheimer’s disease and dementia has announced a new initiative in health systems in five countries to deploy blood biomarkers and confirmatory diagnostic testing to increase timely and accurate diagnosis of Alzheimer’s disease and related dementias. Led by the DAC Healthcare System Preparedness team, the Accurate Diagnosis project is the first-ever global implementation research program to study the use of blood biomarkers as part of the ADRD diagnostic process.


Company updates 

MYndspan study accurately predicts brain age across the lifespan

A new study published in Imaging Neuroscience used MYndspan’s analysis to predict how healthy brains age. With data captured from Magnetoencephalography (MEG), a non-invasive functional brain imaging technology, researchers modelled the trajectories of healthy brain ageing throughout the adult lifespan, identifying markers of accelerated brain ageing brought on by injury or disease.


AI partnership to generate non-invasive brain therapies

The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science have announced a new partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the development of safe, non-invasive ways of treating neurodegenerative and neuropsychiatric disorders. The platform harnesses the power of generative artificial intelligence (AI) to synthesise, on demand, precision sensory stimulation therapies


Awareness of brain health growing, but many too afraid to seek help, survey finds 

A new survey from Parade and Cleveland Clinic shows many Americans (69 per cent) are thinking at least once a year about their risk of developing brain health issues such as Alzheimer’s disease or dementia. However, many do not get care when they experience symptoms. 

In the survey, 36 per cent of people under 50 and nearly one-fourth of individuals aged 50-64 said they have experienced memory or brain health issues but were too afraid to seek help. While there is no cure for Alzheimer’s or dementia, in many cases, steps can be taken to reduce risk but are more effective before brain changes begin.